D3A.095
Benign carcinoid tumor of the midgut, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
A benign carcinoid tumor of the midgut is a non-cancerous growth that originates from specialized hormone-producing cells called enterochromaffin cells, located in the midsection of the digestive system. This type of tumor is classified under ICD-10 code D3A.095. Although it is considered benign, meaning it does not invade nearby tissues aggressively or spread extensively, it still requires medical attention for proper management. The midgut includes parts of the small intestine, such as the jejunum and ileum, as well as the appendix and parts of the colon.
Causes & Symptoms
Clinical Causes: Genetic predisposition, such as inherited syndromes like Multiple Endocrine Neoplasia Type 1 (MEN1). Accumulation of genetic mutations that occur over time. Potential links to environmental factors, though these are not well-established. Histories of previous radiation exposure or certain chronic conditions affecting the gastrointestinal tract.
Key Symptoms: Abdominal pain or discomfort, often intermittent. Digestive disturbances, including nausea, diarrhea, or constipation. Flushing or skin redness due to hormone secretion by the tumor. Unintentional weight loss in some cases. Blood in the stool, if the tumor causes ulceration or bleeding. Feeling of fullness or early satiety after eating.
Diagnostic & Treatment
Diagnosis Path: Medical history review and physical examination. Imaging tests such as computed tomography (CT) scans, magnetic resonance imaging (MRI), or somatostatin receptor scintigraphy (OctreoScan) to identify tumor location and size. Endoscopy procedures, including capsule endoscopy or enteroscopy, to view and possibly biopsy the tumor within the gastrointestinal tract. Laboratory tests measuring hormone levels, like serotonin or 5-HIAA, which can be elevated in carcinoid tumors. Histopathological examination of tissue samples obtained through biopsy to confirm the character of the tumor.
Treatment Protocols: Surgical removal of the tumor is the primary treatment approach. Monitoring through follow-up imaging and blood tests for any recurrence. Medical therapies, such as somatostatin analogs (e.g., octreotide), to control hormone-related symptoms or potentially slow tumor growth. In cases where surgery is not feasible, options may include targeted therapies or peptide receptor radionuclide therapy (PRRT). Nutritional support and symptom management to improve quality of life.
Clinical Advice & FAQs
Billing Guidance
Is D3A.095 a billable ICD-10 code?
Yes, D3A.095 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D3A.095?
Clinical documentation must specify the nature of Benign carcinoid tumor of the midgut, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference